-
1دورية أكاديمية
المؤلفون: Colombo, M., Fernández, I., Abdurakhmanov, D., Ferreira, P. A., Strasser, S. I., Urbanek, P., Moreno, C., Streinu-Cercel, A., Verheyen, A., Iraqi, W., DeMasi, R., Hill, A., Läuffer, J. M., Lonjon-Domanec, I., Wedemeyer, H.
المصدر: Gut; Jul2014, Vol. 63 Issue 7, p1150-1158, 9p
مصطلحات موضوعية: HEPATITIS C treatment, ADVERSE health care events, ANTIVIRAL agents, DRUG efficacy, TELAPREVIR, MEDICATION safety, MEDICAL statistics, THERAPEUTICS
-
2دورية أكاديمية
المؤلفون: Dusheiko, Geoffrey, Wedemeyer, Heiner
المصدر: Gut; Dec2012, Vol. 61 Issue 12, p1647-1652, 6p, 1 Chart
مصطلحات موضوعية: PROTEASE inhibitors, HEPATITIS C virus, ANTIVIRAL agents, TELAPREVIR, BOCEPREVIR, INFECTION treatment
-
3دورية أكاديمية
المؤلفون: Wise, Jacqui
المصدر: BMJ: British Medical Journal; 3/16/2019, Vol. 364 Issue 8191, pl1094-2, 2p
مصطلحات موضوعية: COST effectiveness, CYSTIC fibrosis, NATIONAL health services, PHARMACY, DRUG approval, TELAPREVIR, ECONOMICS
-
4
المؤلفون: D. Bazin-Karra, Daniel Vittecoq, Jean-Marc Ziza, Stanislas Pol, Valérie Thibault, A. Karras, C. Cazorla, François Blanc, David Saadoun, Olivier Lambotte, Olivier Decaux, Lucile Musset, Patrice Cacoub, M. Longuet, M. Resche Rigon, Gilles Pialoux
المساهمون: Immunologie - Immunopathologie - Immunothérapeutique (I3), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service d'hépatologie médicale [CHU Cochin], Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University Hospital and University Jean Monnet, Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), Centre Hospitalier Universitaire [Rennes], Biologie et thérapeutique des pathologies immunitaires (BTPI), Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS), Service de virologie [CHU Pitié-Salpêtrière], Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de médecine interne [CHU Pitié-Salpétrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Immunologie - Immunopathologie - Immunothérapeutique ( I3 ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Service de virologie, Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Pitié-Salpêtrière [APHP], Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Cochin [AP-HP], Biologie et thérapeutique des pathologies immunitaires ( BTPI ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Centre National de la Recherche Scientifique ( CNRS ), Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Pitié-Salpêtrière [APHP]
المصدر: Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2014, 73 (5), pp.831--837. ⟨10.1136/annrheumdis-2012-202770⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2014, 73 (5), pp.831--837. ⟨10.1136/annrheumdis-2012-202770⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2014, 73 (5), pp.831--837. 〈10.1136/annrheumdis-2012-202770〉مصطلحات موضوعية: Male, [SDV]Life Sciences [q-bio], Hepacivirus, medicine.disease_cause, Gastroenterology, Telaprevir, Polyethylene Glycols, Cohort Studies, chemistry.chemical_compound, 0302 clinical medicine, Immunology and Allergy, Chronic, Hepatitis C, Middle Aged, Cryoglobulinemia, Recombinant Proteins, 3. Good health, Treatment Outcome, Combination, 030211 gastroenterology & hepatology, Drug Therapy, Combination, Female, Vasculitis, Oligopeptides, medicine.drug, medicine.medical_specialty, Proline, Hepatitis C virus, Immunology, Neutropenia, Antiviral Agents, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Rheumatology, Drug Therapy, Internal medicine, Boceprevir, Ribavirin, medicine, Humans, Protease Inhibitors, Aged, 030203 arthritis & rheumatology, [ SDV ] Life Sciences [q-bio], business.industry, Interferon-alpha, Hepatitis C, Chronic, Clinical and Epidemiological Research, medicine.disease, chemistry, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::807ab267ae5e63651ba5402cc5987740Test
http://europepmc.org/articles/PMC3995244Test -
5
مصطلحات موضوعية: Male, medicine.medical_specialty, Side effect, Alpha interferon, Interferon alpha-2, Administration, Cutaneous, Gastroenterology, Antiviral Agents, Article, Telaprevir, chemistry.chemical_compound, Internal medicine, Intensive care, Boceprevir, Ribavirin, medicine, Humans, business.industry, Interferon-alpha, General Medicine, Hepatitis C, Hepatitis C, Chronic, Middle Aged, medicine.disease, Recombinant Proteins, Surgery, Regimen, Diabetes Mellitus, Type 1, chemistry, Drug Therapy, Combination, business, Oligopeptides, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25960b0a86d5d9c87e8f8fea53529d8aTest
https://europepmc.org/articles/PMC3736303Test/ -
6دورية أكاديمية
المصدر: BMJ Case Reports; Jul2013, p1-2, 2p
مصطلحات موضوعية: COMBINATION drug therapy, TYPE 1 diabetes, INTERFERONS, RIBAVIRIN, CHRONIC hepatitis C, TELAPREVIR